James W. Green

James W. Green, listed as chief executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Harvard Bioscience Inc and Analogic Corp. In total, 31 filings cover trades dated from 4 January 2016 to 15 August 2025.

On the open market, the record shows 8 purchases worth €608k and 2 sales worth €329k. No amount is published for 1 filing, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 14 share grants and 3 option exercises.

Half of the purchases are above €79k and half below. Across 8 purchases, this insider has always bought alone, with no colleague buying within 30 days.

Most recently, on 19 August 2025, the filings show a transaction in Harvard Bioscience Inc. The last purchase on record was published on 14 June 2024, which is 856 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.